Albemarle
ALB · Specialty Chemicals
$93.67
1.2%H.B. Fuller
FUL · Specialty Chemicals
$49.61
2.5%The short version
- Albemarle is the larger business, with $5.1B of revenue in fiscal 2025 against $3.5B for H.B. Fuller.
- H.B. Fuller grew revenue faster (−2.7%, against −4.4%).
- Albemarle turned more of its sales into free cash flow (13.5% FCF margin, against 3.5% FCF margin).
- H.B. Fuller earned a higher return on the capital invested in it (6.3%, against −2.4%).
| Latest fiscal year | ALB · FY25 | FUL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $12.8B | $2.7B |
| Revenue | $5.1B | $3.5B |
| Free cash flow | $692M | $121M |
| Net income | −$511M | $152M |
| Growth | ||
| Revenue growth | −4.4% | −2.7% |
| 5-year growth | 10.5% | 4.5% |
| Share count change | 0.1% | −2.3% |
| Profitability | ||
| Gross margin | 13.0% | 31.1% |
| Operating margin | −7.1% | — |
| Net margin | −9.9% | 4.4% |
| FCF margin | 13.5% | 3.5% |
| Return on capital | −2.4% | 6.3% |
| Return on equity | −5.2% | 7.9% |
| Balance sheet | ||
| Net debt | $1.7B | $1.9B |
| Net debt / EBITDA | 5.8x | 3.6x |
| Dividends and buybacks | $191M | $111M |
| Valuation & quality | ||
| P/E | — | 13.8x |
| Piotroski F-score | 7 | 7 |
FY16
ALB $2.7B
FUL $2.1B
FY17
ALB $3.1B
FUL $2.3B
FY18
ALB $3.4B
FUL $3.0B
FY19
ALB $3.6B
FUL $2.9B
FY20
ALB $3.1B
FUL $2.8B
FY21
ALB $3.3B
FUL $3.3B
FY22
ALB $7.3B
FUL $3.7B
FY23
ALB $9.6B
FUL $3.5B
FY24
ALB $5.4B
FUL $3.6B
FY25
ALB $5.1B
FUL $3.5B
ALB
FUL
FY16
ALB 22.5%
FUL 9.5%
FY17
ALB 18.6%
FUL 5.2%
FY18
ALB 27.0%
FUL 7.8%
FY19
ALB 18.6%
FUL 7.8%
FY20
ALB 16.2%
FUL 7.8%
FY21
ALB 24.0%
FUL 7.7%
FY22
ALB 33.7%
FUL 8.6%
FY23
ALB 2.6%
FUL 10.1%
FY24
ALB −33.0%
FUL 9.8%
FY25
ALB −7.1%
FUL —
ALB
FUL
FY16
ALB $539M
FUL $132M
FY17
ALB −$13.7M
FUL $111M
FY18
ALB −$154M
FUL $185M
FY19
ALB −$132M
FUL $207M
FY20
ALB −$51.6M
FUL $244M
FY21
ALB −$609M
FUL $117M
FY22
ALB $646M
FUL $127M
FY23
ALB −$828M
FUL $259M
FY24
ALB −$993M
FUL $163M
FY25
ALB $692M
FUL $121M
ALB
FUL
FY16
ALB —
FUL 9.5%
FY17
ALB 6.7%
FUL 4.2%
FY18
ALB 15.8%
FUL 7.3%
FY19
ALB 9.8%
FUL 5.1%
FY20
ALB 6.2%
FUL 5.1%
FY21
ALB 8.2%
FUL 5.6%
FY22
ALB 23.3%
FUL 7.0%
FY23
ALB 1.1%
FUL 6.4%
FY24
ALB −10.9%
FUL 6.8%
FY25
ALB −2.4%
FUL 6.3%
ALB
FUL
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.